Coronary Stents Devices Are Noted to Be Generating the Largest Revenue Among Cardiac Implant Devices Market.
According to IndustryARC, the Cardiac Implants Devices Market will show a significant growth in the next few years and is expected to reach $43.4 Billion by 2020 at a CAGR of 12.5%. It was also noted that the market was $21.4 Billion in 2014.
US, February 1, 2016 (Newswire.com) - Cardiac implants devices are used for augmenting the lifestyle for the population suffering from cardiac diseases. The cardiac implants and devices has evolved extensively in the last few decades from stents, valves and grafts to the current pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT). For implanting these devices, more recently minimally invasive and off-pump surgical procedures are also being used. According to IndustryARC, the Cardiac Implants Devices Market will show a significant growth in the next few years and is expected to reach $43.4 Billion by 2020 at a CAGR of 12.5%. It was also noted that the market was $21.4 Billion in 2014. Request for Sample Data / Brochure: http://industryarc.com/pdfdownload.php?id=2332 MARKET TRENDS AND MARKET GROWTH SPECIFICS: Market Driving Factors: The cardiac implant device market has been growing due to the matured worldwide population having chronic heart diseases as the most prevalent factor for mortality. It is primarily thriving due the emergence of technological advancements and innovation of various devices for the improvement and betterment of lifestyle for the aged population. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), atrial fibrillation and aortic aneurysms and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market. Cardiac Implantable Devices improve the lifestyle and extend the lifespan of millions of people worldwide, by providing accurate and timely treatment. Technological advancements have drastically improved early diagnosis, treatment and epidemiology of various heart diseases and congenital heart ailments in patients. Growth in the cardiac devices market has been limited by the adoption in the ICD, CRT and valves and pacemaker devices but has seen a tremendous adoption rate in the TAVR, stents and CABG graft devices in the last couple of years. Table of contents and insights: http://industryarc.com/Report/2332/Cardiac-Implants-Devices-Market-Analysis-Report.html Hindering Factors for the Market: The hindrance of cardiac device market is related to the expensive innovative technologies in the market. The large number of product recalls especially in the ICD device market has caused drawback in the cardiac device growth. Unavailability of the cardiac device spare part has caused patient apprehension to these devices in the market. The expertise training is a crucial factor which determines the overall growth of the market as it is essential for the healthcare providers to keep themselves well updated with medical knowledge and technical skills regarding increasingly complex cardiac devices. Regional Analysis of the market: The market yet has the potential to grow in the underpenetrated countries of the Latin America and Asia -pacific. It was also observed that in 2014, Americas region contributed to around 60% of the total market revenues, followed by Europe with 22% share, whereas Asia-Pacific and Rest of World had comparatively lesser market shares, despite having a huge market potential due to prevalent chronic cardiac diseases in the aging population in these regions. REPORT SCOPE: Market Segmentation: The Cardiac Implant Devices Market is segmented into broad 4 types based on the following factors: 1. By Devices: Cardiac Resynchronization Therapy Devices (CRT'S), Implantable Cardioverter Defibrillators (ICD'S), Implantable Cardiac Pacemakers (ICPs) and Others. 2. By Disease Conditions: Myocardial Ischemia, Acute Myocardial Infarction, Arrhythmias and Others. 3. By Procedure: Cardiac Resynchronization Therapy (CRT), Minimally Invasive Heart Surgery and Others. 4. By Geography: North America, Europe, APAC and ROW. Note: The above segments are further classified into sub segments, provided in the report. Key Market Players: Mentioning the top players of the Cardiac Implant Device Market which play a key role in the development and shaping this market are: • Abbott Vascular Inc. • Bentley InnoMed GmbH • Medico S.p.A • Boston Scientific Corporation • Biosensors International Group, Ltd. About Us: IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare. IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today. For More Details Contact: Mr. Sanjay Matthews Sales Manager Email: firstname.lastname@example.org Contact sales: 1-614-588-8538 (Ext-101)
- cardiac implant devices market
- cardiac implant devices market analysis
- cardiac implant devices market companies
- cardiac implant devices market forecast
- cardiac implant devices market industry
- cardiac implant devices market report
- cardiac implant devices market share
- cardiac implant devices market size